Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia

E-ISSN： 1873-4286|17|2|94-102

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.2, 2011-01, pp. : 94-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia

By Moghaddam Bita

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 39-44

Springer Publishing Company

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors: Potential Drug Targets for the Treatment of Schizophrenia

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 3, 2002-06 ,pp. : 261-281

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Targeting the Ionotropic Glutamate Receptors in Treating Schizophrenia

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1535-1542

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors as Drug Targets

Current Drug Targets, Vol. 8, Iss. 5, 2007-05 ,pp. : 651-681

Bentham Science Publishers

Access to resources Recommend Favorite

Latest eruptions in metabotropic glutamate receptors

By Toms N.J. Roberts P.J. Salt T.E. Staton P.C.

Trends in Pharmacological Sciences, Vol. 17, Iss. 12, 1996-12 ,pp. : 429-435

Elsevier

Access to resources Recommend Favorite